Maravai LifeSciences Holdings Inc (MRVI)
10.76
+0.06
(+0.56%)
USD |
NASDAQ |
May 15, 14:41
Maravai LifeSciences Holdings Cash from Investing (TTM): -56.82M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -56.82M |
December 31, 2023 | -122.31M |
September 30, 2023 | -127.93M |
June 30, 2023 | -118.25M |
March 31, 2023 | -95.76M |
December 31, 2022 | -267.61M |
September 30, 2022 | -254.75M |
Date | Value |
---|---|
June 30, 2022 | -130.27M |
March 31, 2022 | -133.14M |
December 31, 2021 | 105.66M |
September 30, 2021 | 102.46M |
June 30, 2021 | -26.26M |
March 31, 2021 | -24.78M |
December 31, 2020 | 6.068M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-267.61M
Minimum
Dec 2022
105.66M
Maximum
Dec 2021
-81.69M
Average
-107.01M
Median
Cash from Investing (TTM) Benchmarks
ModivCare Inc | -36.82M |
Dyadic International Inc | 7.450M |
Enveric Biosciences Inc | 0.0117M |
Monopar Therapeutics Inc | 4.928M |
SeaStar Medical Holding Corp | -- |